EE9400326A - Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid - Google Patents

Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid

Info

Publication number
EE9400326A
EE9400326A EE9400326A EE9400326A EE9400326A EE 9400326 A EE9400326 A EE 9400326A EE 9400326 A EE9400326 A EE 9400326A EE 9400326 A EE9400326 A EE 9400326A EE 9400326 A EE9400326 A EE 9400326A
Authority
EE
Estonia
Prior art keywords
preparation
pharmaceutical preparations
preparations containing
peptide analogues
opioid peptide
Prior art date
Application number
EE9400326A
Other languages
English (en)
Inventor
Schiller Peter
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9400326A publication Critical patent/EE9400326A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70Enkephalins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
EE9400326A 1993-01-05 1994-11-03 Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid EE9400326A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9300012A SE9300012D0 (sv) 1993-01-05 1993-01-05 New peptides

Publications (1)

Publication Number Publication Date
EE9400326A true EE9400326A (et) 1996-04-15

Family

ID=20388466

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400326A EE9400326A (et) 1993-01-05 1994-11-03 Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid

Country Status (25)

Country Link
US (1) US5602099A (et)
EP (1) EP0678099A1 (et)
JP (1) JPH08505386A (et)
KR (1) KR960700269A (et)
CN (1) CN1096515A (et)
AP (1) AP508A (et)
AU (1) AU681372B2 (et)
CA (1) CA2152380A1 (et)
CZ (1) CZ171195A3 (et)
EE (1) EE9400326A (et)
FI (1) FI953302A0 (et)
HU (1) HUT72597A (et)
IL (1) IL108169A0 (et)
IS (1) IS4115A (et)
LV (1) LV10962B (et)
MX (1) MX9400255A (et)
NO (1) NO952650L (et)
NZ (1) NZ259597A (et)
PL (1) PL309778A1 (et)
SE (1) SE9300012D0 (et)
SI (1) SI9400005A (et)
SK (1) SK83995A3 (et)
WO (1) WO1994015959A1 (et)
YU (1) YU394A (et)
ZA (1) ZA9455B (et)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854211A (en) * 1993-12-23 1998-12-29 Novo Nordisk A/S Compounds with growth hormone releasing properties
IS4261A (is) * 1994-02-21 1995-08-22 Astra Aktiebolag Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra
IL114046A0 (en) * 1994-06-20 1995-10-31 Astra Ab New opioid peptide antagonists
RU2067000C1 (ru) * 1994-06-29 1996-09-27 Владислав Исакович Дейгин Пептид и способ его получения
US6184208B1 (en) 1994-06-29 2001-02-06 Immunotech Developments Inc. Peptide, a method for its preparation and a pharmaceutical composition containing the peptide
SE9402880D0 (sv) * 1994-08-30 1994-08-30 Astra Ab New peptide derivatives
US5780589A (en) * 1994-11-30 1998-07-14 The United States Of America As Represented By The Department Of Health And Human Services Ultraselective opioidmimetic peptides and pharmacological and therapeutic uses thereof
AU708620B2 (en) * 1995-03-29 1999-08-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0837857A4 (en) * 1995-03-29 1998-08-05 Merck & Co Inc FARNESYL-PROTEIN TRANSFERASE INHIBITORS
DE19512484A1 (de) 1995-04-04 1996-10-17 Bayer Ag Kohlenhydratmodifizierte Cytostatika
SE9600769D0 (sv) * 1996-02-28 1996-02-28 Astra Ab Compounds useful as analgesic
JP2002512625A (ja) * 1997-05-29 2002-04-23 メルク エンド カンパニー インコーポレーテッド 細胞接着阻害薬としての複素環アミド化合物
US6903075B1 (en) 1997-05-29 2005-06-07 Merck & Co., Inc. Heterocyclic amide compounds as cell adhesion inhibitors
US6703381B1 (en) 1998-08-14 2004-03-09 Nobex Corporation Methods for delivery therapeutic compounds across the blood-brain barrier
US6306576B1 (en) * 1999-02-19 2001-10-23 Cleveland Clinic Foundation Diagnostic methods for asthma
US7601739B2 (en) 2003-08-08 2009-10-13 Virgina Commonwealth University Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
CA2580694A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
EP3160497A4 (en) * 2014-06-27 2018-01-17 H. Lee Moffitt Cancer Center And Research Institute, Inc. Conjugates for immunotherapy

Also Published As

Publication number Publication date
LV10962A (lv) 1995-12-20
CN1096515A (zh) 1994-12-21
LV10962B (en) 1997-04-20
FI953302A (fi) 1995-07-04
IL108169A0 (en) 1994-04-12
CA2152380A1 (en) 1994-07-21
FI953302A0 (fi) 1995-07-04
YU394A (sh) 1997-07-31
SI9400005A (en) 1994-12-31
SK83995A3 (en) 1996-09-04
NZ259597A (en) 1996-07-26
CZ171195A3 (en) 1996-09-11
AU681372B2 (en) 1997-08-28
HU9502041D0 (en) 1995-09-28
ZA9455B (en) 1994-07-05
PL309778A1 (en) 1995-11-13
IS4115A (is) 1994-07-06
WO1994015959A1 (en) 1994-07-21
JPH08505386A (ja) 1996-06-11
AP508A (en) 1996-07-22
AP9400605A0 (en) 1994-01-31
HUT72597A (en) 1996-05-28
NO952650L (no) 1995-08-30
NO952650D0 (no) 1995-07-04
AU5844894A (en) 1994-08-15
KR960700269A (ko) 1996-01-19
MX9400255A (es) 1994-07-29
EP0678099A1 (en) 1995-10-25
SE9300012D0 (sv) 1993-01-05
US5602099A (en) 1997-02-11

Similar Documents

Publication Publication Date Title
EE9400455A (et) Peptiidi derivaadid, nende valmistamise protsess, neid sisaldavad ravimpreparaadid ja nende kasutamine
EE9400326A (et) Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid
EE04375B1 (et) Modifitseeritud aminohapped, neid ühendeid sisaldavad ravimid ja nende valmistamise meetod
IL106600A (en) Peptides, pharmaceutical compositions containing the same and processes for the preparation thereof
EE03111B1 (et) Glükokortikosteroidi epimeerid, nende valmistamise protsessid ja neid sisaldavad ravimpreparaadid
EE9900075A (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
GB9113219D0 (en) Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
FI954767A (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
IL85136A0 (en) Peptide derivatives,their preparation and pharmaceutical compositions containing them
NO954146D0 (no) Belagte farmasöytiske preparater
IL103612A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
EE200000380A (et) 11ß-halogeno-7(alfa)-asendatud östratrieenid, neid 11ß-halogeno-7(alfa)-asendatud östratrieene sisaldavate farmatseutiliste preparaatide valmistamise meetodid ja nende kasutamine ravimite valmistamiseks
EE03110B1 (et) Steroidi estrid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid
IT8647666A0 (it) Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
AU7428691A (en) Long-acting liposome peptide pharmaceutical products and processes for the preparation thereof
NZ234268A (en) Vasoactive intestinal peptide analogues, derivatives and pharmaceutical compositions
FI961938A0 (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
IL92268A0 (en) 14alpha,17alpha,ethanoestratriene derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
EE9400148A (et) Tienotiasiini derivaadid, nende valmistamise meetod ja neid sisaldavad farmatseutilised preparaadid
IL109527A0 (en) Substituted piperazines, their preparation and pharmaceutical compostions containing them
IL96216A0 (en) Peptide derivatives,their preparation and pharmaceutical compositions containing them
NO305959B1 (no) Tiosubstituerte cykliske fosfonatforbindelser, anvendelser derav, og farmasoeytiske preparater inneholdende slike forbindelser
IL99389A0 (en) Amino acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IT8748235A0 (it) Peptidi e derivati peptidici, loro preparazione e loro impiego come medicamenti